Clik here to view.
Q1 FY24 Revenue Update
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that is has achieved approximately $4.1m of unaudited revenues for Q1 of FY24, marking a 79% increase on Q1...
View ArticleClik here to view.
Compass Pathways and Journey Clinical establish research collaboration...
Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Journey Clinical, a leading...
View ArticleClik here to view.
Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives...
- Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing business development discussions - Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage...
View ArticleClik here to view.
Quarterly Activities Report: Melodiol Delivers $4.4M in Revenue during Q1...
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to provide the following update on progress for the three month period ended 31 March 2024 (the ‘quarter’), as well as...
View ArticleClik here to view.
Goodness Growth Holdings to Release First Quarter 2024 Results on May 7, 2024
Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers,...
View ArticleClik here to view.
Goodness Growth Provides CREAM & Fire Updates
Josh Rosen to shed Interim title and become Chief Executive Officer; Company provides other key personnel updates – – Company receives a short-term extension of the maturity date on its credit...
View ArticleClik here to view.
Compass Pathways establishes research collaboration with Mindful Health...
Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Mindful Health Solutions (MHS), one...
View ArticleClik here to view.
Goodness Growth Holdings Announces Filing of Application for Summary...
Filing reflects Company's belief that Verano's defense against claims of unlawful conduct is without merit – – Legal filing represents a documentary record and corresponding damages analysis –...
View ArticleClik here to view.
Notice of Annual General Meeting/Proxy Form
Notice is hereby given that the Annual General Meeting (‘Meeting’) of Shareholders of Melodiol Global Health Limited (‘Company’) will be held by virtual meeting facility at 9.30am (WST) on Friday, 31...
View ArticleClik here to view.
Goodness Growth Holdings Announces First Quarter 2024 Results
Q1 2024 revenue of $21.1 million excluding discontinued operations and NY increased 44.5% year-over-year – – Submitted a substantial legal filing on May 2nd in the ongoing litigation with Verano – –...
View ArticleClik here to view.
Compass Pathways announces durable improvement in symptoms through 12 weeks...
Study met primary safety endpoint; administration was well tolerated, with no serious adverse events observed Early and clinically meaningful improvement from baseline in mean CAPS-5 total score (29.5...
View ArticleClik here to view.
Compass Pathways Announces First Quarter 2024 Financial Results and Business...
COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024, COMP006 trial top-line data expected mid-2025 Compass announces...
View ArticleClik here to view.
Mernova’s Strong Progress Continues
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that its wholly owned Canadian subsidiary, Mernova, continues to make strong operational progress....
View ArticleClik here to view.
Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare...
View ArticleClik here to view.
Fungtional Labs
OverviewFungtional Labs is a leading provider of cultivation supplies and food-grade functional mushrooms in North America. The market for food-grade functional mushrooms is estimated to be $69...
View ArticleClik here to view.
Fungtional Labs: Integrated Supply Chain for Mushroom Cultivators in North...
Fungtional Labs is a leading provider of cultivation supplies and food-grade functional mushrooms in North America. The company’s vertically integrated business model provides robust differentiation...
View ArticleClik here to view.
Functional Mushrooms: A Growing Opportunity
Berries aren't the only superfood making waves in recent years. Mushrooms have been gaining a great deal of popularity amongst consumers, particularly as knowledge about their benefits continues to...
View ArticleClik here to view.
The Business Case for Vertical Integration
Business models and go-to-market strategies are important elements of any investment decision. In that regard, a vertically integrated business model offers several unique advantages over traditional...
View ArticleClik here to view.
Functional Mushrooms: A Market Overview
Functional mushrooms are experiencing a surge in popularity as their health and wellness benefits become increasingly well-known. Driven by multiple intersecting trends, this popularity is directly...
View ArticleClik here to view.
Goodness Growth Holdings Announces Closing of Recently Announced Non-Brokered...
Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers,...
View Article